Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Harboring BRAF Mutations
Top Cited Papers
- 10 September 2011
- journal article
- research article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 29 (26), 3574-3579
- https://doi.org/10.1200/jco.2011.35.9638
Abstract
Purpose To investigate the prevalence, distribution, and prognostic role of BRAF mutations in a large cohort of white patients with non–small-cell lung cancer (NSCLC). Patients and Methods A retros...Keywords
This publication has 33 references indexed in Scilit:
- New driver mutations in non-small-cell lung cancerThe Lancet Oncology, 2011
- EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK InhibitorsNew England Journal of Medicine, 2010
- Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomasLaboratory Investigation, 2010
- EML4-ALK: Honing In on a New Target in Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2009
- Screening for Epidermal Growth Factor Receptor Mutations in Lung CancerNew England Journal of Medicine, 2009
- Frequent mutations in the neurotrophic tyrosine receptor kinase gene family in large cell neuroendocrine carcinoma of the lungHuman Mutation, 2008
- New molecularly targeted therapies for lung cancerJournal of Clinical Investigation, 2007
- Somatic Mutations of the HER2 Kinase Domain in Lung AdenocarcinomasCancer Research, 2005
- Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung CancersJNCI Journal of the National Cancer Institute, 2005
- EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic TreatmentJournal of Clinical Oncology, 2005